Journal article
The role of monoamine oxidase inhibitors in current psychiatric practice
Journal of psychiatric practice, Vol.10(4), pp.239-248
07/2004
DOI: 10.1097/00131746-200407000-00005
PMCID: PMC2075358
PMID: 15552546
Abstract
The use of monoamine oxidase inhibitors (MAOIs) by psychiatrists has declined over the past several decades with the expansion of psychiatrists' pharmacologic armamentarium. This trend has also been driven by concern about food and drug interactions and side effects, as well as waning physician experience with these medications. Many psychiatrists, in fact, never prescribe MAOIs. Recent research has liberalized the MAOI diet and identified symptom presentations more likely to respond to these medications. Thus, clinicians must continue to familiarize themselves with the properties of and indications for prescribing MAOIs.
Details
- Title: Subtitle
- The role of monoamine oxidase inhibitors in current psychiatric practice
- Creators
- Jess G Fiedorowicz - The Johns Hopkins Hospital, Dept. of Psychiatry, Baltimore, MD 21287-7131, USAKaren L Swartz
- Resource Type
- Journal article
- Publication Details
- Journal of psychiatric practice, Vol.10(4), pp.239-248
- DOI
- 10.1097/00131746-200407000-00005
- PMID
- 15552546
- PMCID
- PMC2075358
- NLM abbreviation
- J Psychiatr Pract
- ISSN
- 1527-4160
- eISSN
- 1538-1145
- Publisher
- United States
- Grant note
- L30 MH075180 / NIMH NIH HHS L30 MH075180-01 / NIMH NIH HHS
- Language
- English
- Date published
- 07/2004
- Academic Unit
- Psychiatry; Epidemiology; Iowa Neuroscience Institute
- Record Identifier
- 9984065494202771
Metrics
11 Record Views